Review



cross validation  (Kaggle Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Kaggle Inc cross validation
    Cross Validation, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cross validation/product/Kaggle Inc
    Average 86 stars, based on 1 article reviews
    cross validation - by Bioz Stars, 2026-05
    86/100 stars

    Images



    Similar Products

    cross validation  (Genovis Inc)
    93
    Genovis Inc cross validation
    Cross Validation, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cross validation/product/Genovis Inc
    Average 93 stars, based on 1 article reviews
    cross validation - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    cross validation  (Optimus Corp)
    86
    Optimus Corp cross validation
    Cross Validation, supplied by Optimus Corp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cross validation/product/Optimus Corp
    Average 86 stars, based on 1 article reviews
    cross validation - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    cross validation  (Kaggle Inc)
    86
    Kaggle Inc cross validation
    Cross Validation, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cross validation/product/Kaggle Inc
    Average 86 stars, based on 1 article reviews
    cross validation - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    cross validation tool simca p software  (Umetrics)
    86
    Umetrics cross validation tool simca p software
    Cross Validation Tool Simca P Software, supplied by Umetrics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cross validation tool simca p software/product/Umetrics
    Average 86 stars, based on 1 article reviews
    cross validation tool simca p software - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    ada assay cross validation  (Boehringer Ingelheim)
    86
    Boehringer Ingelheim ada assay cross validation
    Ada Assay Cross Validation, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ada assay cross validation/product/Boehringer Ingelheim
    Average 86 stars, based on 1 article reviews
    ada assay cross validation - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    cross pathway validation with sar408701  (Sanofi)
    86
    Sanofi cross pathway validation with sar408701
    The procedures for within-target validation (left side) and cross-pathway validation (right side) of the platform PBPK-QSP model originally developed for T-DM1. AD: Aggregate data; IPD: Individual patient data; mAb: monoclonal antibody; NHP: Non-human primates; PD: pharmacodynamics; PFS: progression-free survival; PK: pharmacokinetics; <t>SAR408701:</t> Tusamitamab ravtansine; (T-)Dxd: trastuzumab deruxtran;; : In vitro cell culture experiment; : In vivo mouse experiment; : In vivo NHP experiment; : Clinical trial data.
    Cross Pathway Validation With Sar408701, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cross pathway validation with sar408701/product/Sanofi
    Average 86 stars, based on 1 article reviews
    cross pathway validation with sar408701 - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    selection operator with cross validation  (Genovis Inc)
    93
    Genovis Inc selection operator with cross validation
    The procedures for within-target validation (left side) and cross-pathway validation (right side) of the platform PBPK-QSP model originally developed for T-DM1. AD: Aggregate data; IPD: Individual patient data; mAb: monoclonal antibody; NHP: Non-human primates; PD: pharmacodynamics; PFS: progression-free survival; PK: pharmacokinetics; <t>SAR408701:</t> Tusamitamab ravtansine; (T-)Dxd: trastuzumab deruxtran;; : In vitro cell culture experiment; : In vivo mouse experiment; : In vivo NHP experiment; : Clinical trial data.
    Selection Operator With Cross Validation, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/selection operator with cross validation/product/Genovis Inc
    Average 93 stars, based on 1 article reviews
    selection operator with cross validation - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    cross validation  (Wolters Kluwer Health)
    86
    Wolters Kluwer Health cross validation
    The procedures for within-target validation (left side) and cross-pathway validation (right side) of the platform PBPK-QSP model originally developed for T-DM1. AD: Aggregate data; IPD: Individual patient data; mAb: monoclonal antibody; NHP: Non-human primates; PD: pharmacodynamics; PFS: progression-free survival; PK: pharmacokinetics; <t>SAR408701:</t> Tusamitamab ravtansine; (T-)Dxd: trastuzumab deruxtran;; : In vitro cell culture experiment; : In vivo mouse experiment; : In vivo NHP experiment; : Clinical trial data.
    Cross Validation, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cross validation/product/Wolters Kluwer Health
    Average 86 stars, based on 1 article reviews
    cross validation - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    cross validation lasso regression  (Genovis Inc)
    93
    Genovis Inc cross validation lasso regression
    The procedures for within-target validation (left side) and cross-pathway validation (right side) of the platform PBPK-QSP model originally developed for T-DM1. AD: Aggregate data; IPD: Individual patient data; mAb: monoclonal antibody; NHP: Non-human primates; PD: pharmacodynamics; PFS: progression-free survival; PK: pharmacokinetics; <t>SAR408701:</t> Tusamitamab ravtansine; (T-)Dxd: trastuzumab deruxtran;; : In vitro cell culture experiment; : In vivo mouse experiment; : In vivo NHP experiment; : Clinical trial data.
    Cross Validation Lasso Regression, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cross validation lasso regression/product/Genovis Inc
    Average 93 stars, based on 1 article reviews
    cross validation lasso regression - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    The procedures for within-target validation (left side) and cross-pathway validation (right side) of the platform PBPK-QSP model originally developed for T-DM1. AD: Aggregate data; IPD: Individual patient data; mAb: monoclonal antibody; NHP: Non-human primates; PD: pharmacodynamics; PFS: progression-free survival; PK: pharmacokinetics; SAR408701: Tusamitamab ravtansine; (T-)Dxd: trastuzumab deruxtran;; : In vitro cell culture experiment; : In vivo mouse experiment; : In vivo NHP experiment; : Clinical trial data.

    Journal: medRxiv

    Article Title: Translational PBPK-QSP modeling platform for antibody-drug conjugates (ADC): within-target and cross-pathway validation to bridge preclinical and clinical results

    doi: 10.64898/2026.01.30.26345218

    Figure Lengend Snippet: The procedures for within-target validation (left side) and cross-pathway validation (right side) of the platform PBPK-QSP model originally developed for T-DM1. AD: Aggregate data; IPD: Individual patient data; mAb: monoclonal antibody; NHP: Non-human primates; PD: pharmacodynamics; PFS: progression-free survival; PK: pharmacokinetics; SAR408701: Tusamitamab ravtansine; (T-)Dxd: trastuzumab deruxtran;; : In vitro cell culture experiment; : In vivo mouse experiment; : In vivo NHP experiment; : Clinical trial data.

    Article Snippet: For cross-pathway validation with SAR408701 (tusamitamab ravtansine), we thankfully acknowledge the provision of data from the ADC development at Sanofi, which are not publicly available, though.

    Techniques: Biomarker Discovery, Drug discovery, In Vitro, Cell Culture, In Vivo